- POSITIVE
Annual Revenue Royal Sense Mar-2026 Annual Revenue is Rs 38 Cr which is growth of 36.5% YoY.
- NEGATIVE
Annual Net Profit Royal Sense Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of -1.1% YoY.
aboutRoyal Sense Ltd. is a supplier and trader specializing in medical equipment, surgical instruments, and laboratory consumables. The company primarily serves the healthcare sector, providing a wide range of products to hospitals, diagnostic centers, an... Read More
67.70-6.30(-8.51%)
500
BSE Volume
BSE 03 Nov, 2026 3:31 PM (IST)
Please subscribe to view forecaster data
Check Before You Buy
VIEW FULL CHECKLISTLow rank
4Positive10Negative
28.6%Pass in checklist
Check P/E Buy Sell Zone
Not enough data available
Royal Sense Stock Price Analysis
Day Price Range-8.5% 1 Day return | 67.7 (LTP) 67.767.7 LowHigh |
|---|---|
Week Price Range-1.0% 1 Week return | 67.7 (LTP) 6674 LowHigh |
Month Price Range-23.1% 1 Month return | 67.7 (LTP) 6689.2 LowHigh |
52 Week Price Range-70.7% 1 Year return | 67.7 (LTP) 66255.9 LowHigh |
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Royal Sense annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Jun '23 |
|---|---|---|---|---|---|---|
101.8% | 37.8 | 27.7 | 19 | 4.6 | ||
Operating Exp. Ann. | 101.9% | 32.9 | 23.4 | 16.6 | 4 | |
Operating Profit Ann. | 90% | 4.8 | 4.3 | 2.4 | 0.7 | |
OPM Ann. % | -4.9% | 12.73% | 15.32% | 12.47% | 14.80% | |
103.7% | 33.8 | 23.6 | 16.7 | 4 | ||
EBITDA Ann. | 91.3% | 4.9 | 4.3 | 2.4 | 0.7 | |
EBITDA Ann. margin % | -4.3% | 12.97% | 15.61% | 12.63% | 14.80% | |
Interest Ann. | - | 0.8 | 0.2 | 0 | ||
Depr. | - | 0.1 | 0 | 0.1 | ||
PBT Ann. | 80.3% | 4.1 | 4.1 | 2.3 | 0.7 | |
Tax Ann. | 71% | 1 | 1.1 | 0.6 | 0.2 | |
81.7% | 3 | 3 | 1.7 | 0.5 | ||
Net Profit Ann. | 81.7% | 3 | 3 | 1.7 | 0.5 | |
NPM Ann. % | -9.9% | 7.98% | 11.01% | 8.97% | 10.91% | |
EPS Adj. latest Ann. | 77.6% | 5.6 | 5.7 | 3.2 | 1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
36.5%
2Y CAGR
41%
3Y CAGR
101.8%
Net Profit Ann.
2Y CAGR
32.8%
3Y CAGR
81.7%
Operating Exp. Ann.
1Y CHG
40.6%
2Y CAGR
40.8%
3Y CAGR
101.9%
Royal Sense Technical Analysis
Royal Sense EMA & SMA
Bearish-8
0 bullish, 8 bearish
Bullish0
Bearish8
| 5 Day | 70.3 |
|---|---|
| 10 Day | 71.4 |
| 12 Day | 72.1 |
| 20 Day | 75.1 |
| 26 Day | 77.4 |
|---|---|
| 50 Day | 85.5 |
| 100 Day | 101.7 |
| 200 Day | 129.4 |
Royal Sense Delivery And Volume
Daily Avg. Delivery Volume %
03 Nov, 2026100.0%
Week100.0%
Month95.4%
Royal Sense Active Candlesticks
Short Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Royal Sense Resistance and Support
67.70
Pivot
| First Resistance | 67.7 |
|---|---|
| Second Resistance | 67.7 |
| Third Resistance | 67.7 |
| First Support | 67.7 |
|---|---|
| Second Support | 67.7 |
| Third Support | 67.7 |
| Day RSI | 36.6 |
|---|---|
| Day MACD | -5.4 |
| Day MFI | 34.9 |
| Day MACD Signal Line | -5.9 |
Royal Sense Beta
| 1 Month | -0.1 |
|---|---|
| 1 Year | -0.1 |
| 3 Month | -0.2 |
|---|---|
| 3 Year | - |
Royal Sense Price Change Analysis
↓-23.1%
Over 1 Month
LowHigh
66.089.3
↓-36.1%
Over 3 Months
LowHigh
66.0110
↓-56.8%
Over 6 Months
LowHigh
66.0156.2
↓-70.7%
Over 1 Year
LowHigh
66.0255.9
Royal Sense Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| PJS SECURITIES LLP | Bulk | Sell | 22 Oct 2026 | 69.97 | 31,500 | BSE |
| SIDHACHAKRA ENTERPRISE LLP | Bulk | Purchase | 22 Oct 2026 | 69.97 | 31,500 | BSE |
| KADAYAM RAMANATHAN BHARAT | Bulk | Purchase | 04 Apr 2024 | 134.96 | 34,000 | BSE |
| RIKHAV SECURITIES LIMITED | Bulk | Purchase | 04 Apr 2024 | 137.78 | 10,000 | BSE |
| RIKHAV SECURITIES LIMITED | Bulk | Sell | 04 Apr 2024 | 141.31 | 82,000 | BSE |
| LATHE DERIVATIVES TRADING PRIVATE LIMITED . | Bulk | Sell | 04 Apr 2024 | 140.64 | 26,000 | BSE |
| LATHE DERIVATIVES TRADING PRIVATE LIMITED . | Bulk | Purchase | 04 Apr 2024 | 144.57 | 30,000 | BSE |
| BHARTIDEVI MOHANLAL DUHLANI | Bulk | Sell | 26 Mar 2024 | 108.79 | 34,000 | BSE |
| HARYANA REFRACTORIES PRIVATE LIMITED | Bulk | Sell | 21 Mar 2024 | 119.36 | 34,000 | BSE |
| MANOJ AGARWAL | Bulk | Purchase | 20 Mar 2024 | 116.61 | 30,000 | BSE |
Royal Sense Corporate Actions
Royal Sense Board Meetings
Royal Sense past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
117 Jul 2026 | Others | Inter-alia, to consider 1. Approve the increase in the Authorised Share Capital of the Company & consequent alteration of the Capital Clause of the MOA. 2. Other business matters. |
225 May 2026 | Audited Results | - |
313 Nov 2025 | Half Yearly Results | - |
426 May 2025 | Scheme of Arrangement | - |
519 May 2025 | Audited Results | (Revised) |
Royal Sense Corporate Filings
Royal Sense BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 26 Oct 2026 | Royal Sense Ltd - 544143 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 | The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 26, 2026 for Rishabh Arora | |
| 05 Oct 2026 | Royal Sense Ltd - 544143 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Compliance Certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018 | |
| 05 Oct 2026 | Royal Sense Ltd - 544143 - Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th October, 2026 | Outcome of Board meeting- Appointment of secretarial and internal auditor of the company | |
| 29 Sep 2026 | Royal Sense Ltd - 544143 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | Scrutinizer Report for the AGM held on 28th September, 2026 | |
| 28 Sep 2026 | Royal Sense Ltd - 544143 - Shareholder Meeting / Postal Ballot-Outcome of AGM | Proceedings of the 3rd Annual General Meeting held on 28th September, 2026 |
Royal Sense - Company Profile
Royal Sense Management Structure
Royal Sense management structure with salaries, total experience, and qualifications.
Royal Sense Board of Directors
Royal Sense Board of directors with salaries, total experience, and qualifications.
Website: www.royalsense.in
About the company - Business Profile
Royal Sense Ltd. is a supplier and trader specializing in medical equipment, surgical instruments, and laboratory consumables. The company primarily serves the healthcare sector, providing a wide range of products to hospitals, diagnostic centers, and medical institutions. It plays a critical role in the healthcare supply chain by ensuring the availability of essential medical tools and consumables required for clinical and surgical procedures.
Key Points
- Key Facts:
- Managing Director: Rishabh Arora.
- Registered Office: C-7, Phase-3, Badli Industrial Area, Badli, North West Delhi, Delhi-110042.
- Stock Listing: Listed on the BSE (Scrip Code: 544143, Symbol: ROYAL).
- Status: Public limited company.
- Operations and Resources: The company operates out of its registered office and distribution facility in Delhi. Its core operations involve the sourcing, stocking, and distribution of medical and surgical goods. Notable assets include an inventory of approximately ₹1,476.27 Lakhs as of September 2025, which is essential for maintaining its supply-driven business model.
- Market and Significance: Royal Sense Ltd. serves various medical professionals and healthcare facilities, providing critical items such as surgical instruments and laboratory supplies. Its strategic importance lies in its ability to manage a diverse portfolio of medical consumables and deliver them to a highly regulated and essential industry.
- Business Model and Core Competencies: The company follows a trading and distribution-led business model. It is proficient in supply chain management, procurement of specialized medical instruments, and maintaining a robust distribution network. Its strengths lie in its established relationships with medical manufacturers and its ability to maintain high inventory levels (₹1,476.27 Lakhs in Sept 2025 vs. ₹575.34 Lakhs in March 2025) to meet fluctuating market demand.
- Revenue and Financial Performance:
- Annual Revenue (FY2025): ₹6,173.40 Lakhs (Year ended March 31, 2025).
- Annual Revenue (FY2024): ₹1,700.02 Lakhs (Year ended March 31, 2024).
- Profit After Tax (FY2025): ₹433.12 Lakhs.
- Profit After Tax (FY2024): ₹158.53 Lakhs.
- Half-Yearly Performance (Ended Sept 2025): Revenue of ₹4,341.34 Lakhs with a net profit of ₹405.60 Lakhs.
- Strategic Initiatives: The company has recently focused on scaling its operations, as evidenced by a 263% year-on-year increase in annual revenue from FY2024 to FY2025. It is also expanding its working capital base, with short-term borrowings increasing to ₹590.50 Lakhs by September 2025 to support larger inventory and trade receivables.